ENT Infections

  • Clindamycin should not be used for empiric treatment due to increasing resistance

  • The listed oral antibiotics have excellent or very good bioavailability

  • MRSA coverage not required empirically except in critically ill patients with purulent head/neck infections including otitis externa

  • Pseudomonas coverage not required empirically except in otitis externa

  • Control the source of infection, and send appropriate specimens to the microbiology laboratory

More Information

(1) Pocket Guide to Antimicrobial Therapy in Otolaryngology – Head and Neck Surgery, 13th Edition (American Academy of Otolaryngology)

(2) Infectious Diseases Society of America Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults

(3) The Sanford Guide To Antimicrobial Therapy 2016, 46th Edition

Guideline adapted from Providence Health Care

Terms of Use | Feedback
© Copyright 2021 Spectrum Mobile Health Inc., dba Firstline Clinical. All rights reserved.